Impact Biomedical shares drop 21.43% in premarket due to technical correction and dilution concerns from merger deal.

miércoles, 25 de junio de 2025, 5:54 am ET1 min de lectura
IBO--
Impact Biomedical Inc. plunged 21.43% in premarket trading, following a technical correction after recent significant gains and concerns over potential share dilution due to ongoing acquisition and equity restructuring.

Impact Biomedical shares drop 21.43% in premarket due to technical correction and dilution concerns from merger deal.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios